Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Aris

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Shock (Augusta, Ga.)|June 5, 2007
Molecular signatures of trauma-hemorrhagic shock-induced lung injury: hemorrhage- and injury-associated genesRena Feinman, Edwin A Deitch, Virginie Aris, et al.
JCO Precision Oncology|April 23, 2025
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion CancerMarcia S Brose, C Benedikt Westphalen, Xiaoyun Pan, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Shock (Augusta, Ga.)|June 5, 2007
Molecular signatures of trauma-hemorrhagic shock-induced lung injury: hemorrhage- and injury-associated genesRena Feinman, Edwin A Deitch, Virginie Aris, et al.
JCO Precision Oncology|April 23, 2025
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion CancerMarcia S Brose, C Benedikt Westphalen, Xiaoyun Pan, et al.
Pageof 2